Melatonin in neuroskeletal biology

Area of Science:

• Neuroscience and Endocrinology
• Gerontology
• Skeletal Biology

Background:

• Osteoporosis and neurodegenerative diseases are prevalent in aging populations.
• Emerging research highlights the interplay between the nervous, skeletal, and muscular systems in maintaining bone health.
• The nervous system's direct regulation of bone remodeling suggests osteoporosis is a neuroskeletal disease.

Purpose of the Study:

• To review recent advancements in using melatonin for preventing age-related osteoporosis (senile, postmenopausal) and neurodegenerative osteoporosis.
• To explore the influence of neuromuscular systems on bone homeostasis.
• To provide insights into the neuroskeletal basis of osteoporosis.

Main Methods:

• Literature review of preclinical and clinical studies.
• Analysis of research on melatonin's role in bone remodeling and neuroprotection.
• Synthesis of findings on neuroskeletal interactions in osteoporosis.

Main Results:

• Melatonin, a pineal gland hormone, acts on MT1 and MT2 receptors, affecting diverse bodily systems.
• Melatonin is utilized in various pharmaceutical and nutraceutical products for disease prevention and treatment.
• Evidence suggests melatonin's potential benefits for osteoporosis and neurodegenerative conditions.

Conclusions:

• Melatonin shows promise in preventing various forms of osteoporosis linked to aging and neurodegeneration.
• Understanding neuroskeletal biology is crucial for developing effective osteoporosis therapies.
• Further preclinical and clinical studies are essential to validate melatonin's therapeutic potential in neuroskeletal health.